Department of Molecular Pathogenesis
National Cerebral and Cardiovascular Center Research Institute
Kishibeshinmachi, Suita, Osaka, Japan

Dr. Harada Shiba makes the following disclosures:   Stock holding: Liid Pharma.  Honoraria: Amgen, Astellas, Sanofi, Recordati, MSD, Mochida.  Scholarship grants: Recordati, Kaneka